Neurotech International Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.007x

Neurotech International Ltd cash flow conversion efficiency. Based on the latest financial reports, Neurotech International Ltd (NTI) has a cash flow conversion efficiency ratio of -0.007x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-38.33K ≈ $-27.12K USD) by net assets (AU$5.88 Million ≈ $4.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Neurotech International Ltd (2015–2026)

Cash flow conversion efficiency of Neurotech International Ltd from 2015 to 2026. This chart illustrates how Neurotech International Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Neurotech International Ltd stock quote for real-time trading data and today's change.

Neurotech International Ltd Cash Flow Conversion Ratio Explained

Neurotech International Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Neurotech International Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neurotech International Ltd ranked by their cash flow conversion efficiency. Also see how much is Neurotech International Ltd worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Mgenplus Co. Ltd. KQ:032790	-0.049x
Lyckegard Group AB ST:LYGRD	0.233x
Birko Birlesik Koyunlulular Mensucat Ticaret ve Sanayi AS IS:BRKO	0.031x
Rathbone Brothers PLC LSE:RAT	0.142x
IXUP Ltd AU:IXU	-0.742x
BOXABL Inc. NASDAQ:BXBL	-0.230x
Gold Strike Resources Corp. V:GSR	-0.169x
Rectitude Holdings Ltd Ordinary Shares NASDAQ:RECT	-0.063x

Annual Cash Flow Conversion Efficiency for Neurotech International Ltd (2015–2026)

The table below shows the annual cash flow conversion efficiency of Neurotech International Ltd from 2015 to 2026. Review financial flexibility index of Neurotech International Ltd to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-06-30	AU$611.14K ≈ $432.42K	AU$-4.22 Million ≈ $-2.99 Million	-6.912x	-126.31%
2025-06-30	AU$2.95 Million ≈ $2.09 Million	AU$-9.02 Million ≈ $-6.39 Million	-3.054x	-690.85%
2024-06-30	AU$11.90 Million ≈ $8.42 Million	AU$-4.60 Million ≈ $-3.25 Million	-0.386x	+75.78%
2023-06-30	AU$3.96 Million ≈ $2.80 Million	AU$-6.32 Million ≈ $-4.47 Million	-1.594x	+22.85%
2022-06-30	AU$1.43 Million ≈ $1.01 Million	AU$-2.96 Million ≈ $-2.09 Million	-2.067x	-244.48%
2021-06-30	AU$3.86 Million ≈ $2.73 Million	AU$-2.32 Million ≈ $-1.64 Million	-0.600x	-156.78%
2020-06-30	AU$-646.29K ≈ $-457.29K	AU$-682.83K ≈ $-483.15K	1.057x	+112.36%
2019-06-30	AU$297.41K ≈ $210.44K	AU$-2.54 Million ≈ $-1.80 Million	-8.551x	-1095.71%
2018-06-30	AU$4.23 Million ≈ $2.99 Million	AU$-3.03 Million ≈ $-2.14 Million	-0.715x	+1.59%
2017-06-30	AU$4.30 Million ≈ $3.04 Million	AU$-3.12 Million ≈ $-2.21 Million	-0.727x	-1239.04%
2016-06-30	AU$14.48 Million ≈ $10.25 Million	AU$-785.79K ≈ $-555.99K	-0.054x	+91.75%
2015-12-31	AU$1.29 Million ≈ $916.07K	AU$-851.21K ≈ $-602.29K	-0.657x	--

About Neurotech International Ltd

AU:NTI Australia Biotechnology

Market Cap

$18.30 Million

AU$25.86 Million AUD

Market Cap Rank

#25215 Global

#1050 in Australia

Share Price

AU$0.02

Change (1 day)

-5.88%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$0.48